A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent ...
Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...
The advisory comes after the implementation of Phase IV of the Graded Response Action Plan (GRAP) in the Delhi-NCR region amid deteriorating air quality.
Up to $54.3 million CEPI investment aims to help advance Moderna’s H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...
Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has signaled smart money ...
Dompé, a leading biopharmaceutical company with operations in Italy and the U.S., announced the first patients have been enrolled in a Phase 3 study of Isocyclosporin for the treatment of atopic ...
Strategic communication for us is no longer optional for India, but it is a prerequisite for national security ...
Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company ...
Phase 1 data presented by Andrew Brenner, MD, PhD, showed RNL-186 improved survival, reduced symptoms, and demonstrated ...
From reference-grade loudspeakers and AV processors to subwoofers and headphones, 2025 delivered standout audio and home ...
H-bridge buck-boost ICs are widely used in applications requiring a constant voltage or current source even when the system ...
The Africa Centres for Disease Control and Prevention (Africa CDC) says the continent is moving closer to meeting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback